|
Volumn 132, Issue , 2007, Pages 31-50
|
NCI's cancer therapy evaluation program: a commitment to treatment trials.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CLINICAL TRIAL;
HEALTH CARE ORGANIZATION;
HUMAN;
METHODOLOGY;
NEOPLASM;
REVIEW;
STANDARD;
STATISTICS;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
NEOPLASMS;
RESEARCH DESIGN;
UNITED STATES;
MLCS;
MLOWN;
|
EID: 33947275414
PISSN: 09273042
EISSN: None
Source Type: Journal
DOI: 10.1007/978-0-387-33225-3_3 Document Type: Review |
Times cited : (3)
|
References (12)
|